C5orf46 and digestive system neoplasm: The expression levels of C5ORF46 were significantly higher in stage II than in stage I. Intriguingly, most of the GI tumors tended to have the lowest expression levels of C5ORF46 in stage I. We found that C5ORF46 expression was particularly higher in younger patients (age ≤65) in ESCA.